GSK3 inhibitor ameliorates steatosis through the modulation of mitochondrial dysfunction in hepatocytes of obese patients. Yaqiong Li et al

Published: 09-03-2021| Version 2 | DOI: 10.17632/54rxxvrwxr.2
Contributor:
Haiyan Zhang

Description

All original, unprocessed images of western blot in the paper.

Files